Hyperhomocysteinemia and changed plasma thiol redox status in chronic obstructive pulmonary disease

Clinical Chemistry and Laboratory Medicine

Volumn 39, Issue 3, 2001, Pages 229-233

  Andersson, A ^a   Ankerst, J ^a   Lindgren, A ^a   Larsson, K ^a   Hultberg, B ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Homocysteine; Lung diseases; Oxidative stress; Sulphydryl compounds

Indexed keywords

CYSTEINE; CYSTEINYLGLYCINE; FREE RADICAL; GLUTATHIONE; GLUTATHIONE DISULFIDE; HOMOCYSTEINE; THIOL;

ADULT; AGED; AMINO ACID BLOOD LEVEL; AMINO ACID METABOLISM; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; EXTRACELLULAR SPACE; FEMALE; HUMAN; HYPERHOMOCYSTEINEMIA; HYPOTHESIS; LUNG DISEASE; MALE; OXIDATION; OXIDATION REDUCTION STATE; PATHOGENESIS; PLASMA; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; CYSTEINE; DIPEPTIDES; FEMALE; FREE RADICALS; GLUTATHIONE; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; LUNG DISEASES, OBSTRUCTIVE; MALE; MIDDLE AGED; OXIDATION-REDUCTION; SULFHYDRYL COMPOUNDS;

EID: 0035040446     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2001.036     Document Type: Article

References (33)

1. Plasma homocysteine and cardiovascular disease
2. Homocysteine and cardiovascular disease
3. Plasma homocysteine as a risk factor for vascular disease. The European converted action project
4. Hyperhomocysteinemia as a risk factor for arterial and venous disease. A review of evidence and relevance [review]
5. Plasma homocyst(e)ine and arterial occlusive diseases. A mini-review
6. Low circulating folate and vitamin B6 concentrations. Risk factors for stroke, peripheral vascular disease, and coronary artery disease. European COMAC Group
7. Disorders of transsulfuration
8. Homocysteine and other thiols determined in plasma by HPLC and thiol-specific postcolumn derivatization
9. Total homocysteine in plasma and serum: Methods and clinical applications [review]
10. Effect of thiol oxidation and thiol export from erythrocytes on determination of redox status of homocysteine and other thiols in plasma from healthy subjects and patients with cerebral infarction
11. Reduced, free and total fractions of homocysteine and other thiol compounds in plasma from patients with renal failure
12. Thiols as a measure of plasma redox status in healthy subjects and in patients with renal or liver failure
13. Redox status of plasma homocysteine and other plasma thiols in stroke patients
14. Oxidation products of uric acid and ascorbic acid in preterm infants with chronic lung disease
15. Uric acid and ascorbic acid redox ratios in plasma and tracheal aspirate of preterm babies with acute and chronic lung diseases
16. Homocysteine species as components of plasma redox thiol status
17. The redox state as a correlate of senescence and wasting and as a target for therapeutic intervention
18. The oxidation hypothesis of atherosclerosis
19. The oxidant stress of hyperhomocyst(e)inemia
20. Impairment of endothelial functions by acute hyperhomocysteinemia and reversal by antioxidant vitamins
21. Enhanced in vivo lipid peroxidation at elevated plasma total homocysteine levels
22. Lipid peroxidation and susceptibility of low-density lipoprotein to in vitro oxidation in hyperhomocysteinaemia
23. Circulating lipid hydroperoxide levels in human hyperhomocysteinemia. Relevance to development of arteriosclerosis
24. How the lung deals with oxidants
25. Reactive oxygen species and the lung
26. Linoleic acid and protein thiol changes suggestive of oxidative damage in the plasma of patients with adult respiratory distress syndrome
27. The effect of a subnormal vitamin B-6 status on homocysteine metabolism
28. Determination of reduced, oxidized, and protein-bound glutathione in human plasma with precolumn derivatization with monobromobimane and liquid chromatography
29. Determination of in vivo redox status of cysteine, cysteinylglycine, homocysteine and glutathione in human plasma
30. Reactive oxygen species in acute lung injury
31. Total homocysteine in plasma or serum: Methods and clinical applications
32. Reduced, oxidized and protein-bound forms of homocysteine and other aminothiols in plasma comprise the redox thiol status - A possible element of the extracellular antioxidant defense system
33. Plasma homocysteine and thiol compound fractions after oral administration of N-acetylcysteine